Beijing Succeeder Technology Inc.

Ca²⁺ inoita basa rakakosha mukuita kwekugwamba kweropa, kunyanya kusanganisira zvinotevera:

1. Kubatanidzwa mukushanda kwezvinhu zvinodzivirira kuvharika kweropa:
Zvinhu zvakawanda zvinobatanidza majoini zvinoda kuti Ca²⁺ ishande pamwe chete kana ichiita basa rayo. Semuenzaniso, mukuita kuti majoini ashande IX, X, XI, XII, nezvimwewo, Ca²⁺ inofanirwa kubatana nezvinhu izvi zvinobatanidza majoini kuti zviite shanduko dzechimiro uye kuburitsa pachena nzvimbo inoshanda, kuitira kuti zvigone kudyidzana nezvimwe zvinhu zvinobatanidza majoini uye kutanga maitiro ejoini.

2. Kukurudzira kuumbwa kwe coagulation factor complexes:
Ca²⁺ inogona kushanda sebhiriji kukurudzira kuumbwa kwema complexes pakati pezvinhu zvinobatanidza ma platelet. Semuenzaniso, mukuita kwe coagulation, Ca²⁺ inogona kubatanidza ma phospholipid ane negative charge (ari pamusoro pe platelet membranes, nezvimwewo) nezvinhu zvinobatanidza ma platelet Xa, V, nezvimwewo kuti vagadzire prothrombin complexes, zvichikurumidzisa maitiro ekushandurwa kwe prothrombin kuita thrombin.

3. Kushanda uye kuburitswa kwemaplatelet:
Ca²⁺ inokoshawo zvikuru pakushanda nekusunungura maitiro emaplatelet. Kana mitsipa yeropa yakuvara, maplatelet anonamatira pachikamu chakakuvara, uye Ca²⁺ inopinda mumaplatelet, zvichikonzera maitiro akasiyana-siyana emabiochemical mumaplatelet, zvichikonzera kuburitswa kwezvinhu zvakasiyana-siyana zvinoshanda kubva kumaplatelet, zvakaita seadenosine diphosphate (ADP), thromboxane A₂, nezvimwewo. Zvinhu izvi zvinowedzera kukurudzira kuunganidzwa kwemaplatelet uye kuvharika kweropa.

4. Kusimbisa mapolima efibrin:
Padanho rekupedzisira rekugwamba kweropa, fibrinogen inoshandurwa kuita fibrin monomers pasi pechiito chethrombin, uye ipapo fibrin monomers dzinobatanidzwa kuti dzigadzire stable fibrin polymers pasi pechiito cheCa²⁺ uye coagulation factor XIII, nokudaro dzichigadzira blood clot yakasimba kuti zvizadzise chinangwa che hemostasis. Pasina Ca²⁺, fibrin monomers haigone kubatanidzwa kuita stable fibrin polymers, blood clot haigone kuumbwa zvakanaka, uye ropa harigone kubatanidzwa zvakanaka.

Beijing Succeeder Technology Inc. (Stock code: 688338), yakavambwa muna 2003 uye yakanyorwa kubva muna 2020, ikambani inotungamira mukugadzira ma "coagulation diagnostics". Isu tine hunyanzvi mu "automated coagulation analyzers" uye "reagents", "ESR/HCT analyzers", uye "hemorheology analyzers". Zvigadzirwa zvedu zvakanyoreswa pasi peISO 13485 neCE, uye tinoshandira vashandisi vanopfuura zviuru gumi pasi rese.

Nhanganyaya yeAnalyzer
Chinoongorora Kugwinya Kweropa Zvizere SF-9200 (https://www.succeeder.com/fully-automated-coagulation-analyzer-sf-9200-product) chinogona kushandiswa pakuongorora kwekiriniki uye pakuongorora vasati vavhiyiwa. Zvipatara nevaongorori vesainzi yezvekurapa vanogonawo kushandisa SF-9200. Iyo inoshandisa kugwinya kweropa uye immunoturbidimetry, nzira yechromogenic yekuedza kugwinya kweropa. Chishandiso ichi chinoratidza kuti kukosha kwekuyera kugwinya kweropa inguva yekugwinya kweropa (mumasekondi). Kana chinhu chekuedza chikaongororwa neplasma yekuyera, chinogonawo kuratidza mimwe mhedzisiro yakabatana.
Chigadzirwa ichi chakagadzirwa nechikamu chinofambiswa chekuongorora sampling probe, chikamu chekuchenesa, chikamu chinofambiswa checuvettes, chikamu chekudziisa nekutonhodza, chikamu chekuyedza, chikamu chinoratidzwa nekushanda, LIS interface (inoshandiswa pakudhinda uye zuva rekuchinjisa kuComputer).
Vashandi vane ruzivo uye vanoongorora vane hunhu hwepamusoro uye manejimendi akasimba ndivo vanovimbisa kugadzirwa kweSF-9200 uye yemhando yepamusoro. Tinovimbisa kuti chishandiso chega chega chakaongororwa uye chakaedzwa zvakasimba. SF-9200 inosangana nechiyero chenyika yeChina, chiyero cheindasitiri, chiyero chebhizinesi uye chiyero cheIEC.